Health Condition 1: null- Superficial cutaneous dermatophyte infection
Conditions
Interventions
Intervention1: Oral Griseofulvin tablet: oral griseofulvin-10mg/kg/day (with a range of 10-15 mg/kg) for tinea corporis without scalp/ hair disease and 20 mg/kg/day for disease on scalp ( with a rang
Sponsors
DR NILENDU SARMA
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinical diagnosis of superficial dermatophyte infection of skin and hair confirmed by KOH smear 2.Lesion number has to be two or more if previously untreated 3.Single lesion disease with a past history of poor/ incomplete response to any form of antifungal treatment (topical or oral).
Exclusion criteria
Exclusion criteria: 1. Unwilling patients or parents 2. Serious disease 3. Presence of onychomycosis 4. Contraindication to griseofulvin or fluconazole 5. Liver and kidney functional disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic efficacy of oral griseofulvin in comparison to oral fluconazole in superficial dermatophyte infection among post infant pediatric population (1-12 years)Timepoint: For tinea corporis â?? about 6 weeks with a range of 2-8 weeks. For tinea capitis is 12 weeks with a range of 6-14 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of demographic, socioeconomic parameters and self-medication habits with clinical patterns, severity, resistance of the superficial fungal infection.Timepoint: For tinea corporis â?? about 6 weeks with a range of 2-8 weeks. For tinea capitis is 12 weeks with a range of 6-14 weeks. | — |
Countries
India
Contacts
Public ContactDr Nilendu Sarma
Department of Dermatology, Dr B C Roy Post Graduate Institute of Pediatric Science
Outcome results
None listed